Q3 2025 CVS Health Corp Earnings Call Transcript
Key Points
- CVS Health Corp (CVS) reported a strong third quarter with adjusted operating income of $3.5 billion and adjusted earnings per share of $1.60, reflecting a 47% increase from the prior year.
- The company raised its full-year 2025 adjusted earnings per share guidance to a range of $6.55 to $6.65, up from the previous range of $6.30 to $6.40.
- CVS Health Corp (CVS) achieved new client wins of nearly $6 billion in its pharmacy benefit management (PBM) segment, with a high retention rate in the 90s.
- The Aetna business showed significant improvement, with over 81% of Medicare Advantage members expected to be in plans rated 4 stars or higher.
- The Pharmacy & Consumer Wellness segment delivered strong performance, with revenues increasing nearly 12% year-over-year, driven by pharmacy drug mix and increased prescription volume.
- CVS Health Corp (CVS) recorded a $5.7 billion goodwill impairment within its healthcare delivery segment due to tempered growth expectations for Oak Street Health clinics.
- The company faced pressures in its PBM segment due to changes in drug mix and utilization patterns, impacting near-term growth outlook.
- There was a decrease in medical membership by approximately 445,000 members from the prior year quarter, primarily driven by declines in individual exchange and Medicare product lines.
- The Health Services segment saw a 7% decrease in adjusted operating income from the prior year quarter, primarily due to continued pharmacy client price improvements.
- The company continues to face reimbursement pressure in its Pharmacy & Consumer Wellness segment, impacting adjusted operating income.
Hello and welcome to CVS Health's third quarter 2025 earnings call. (Operator Instructions)As a reminder, this conference is being recorded today.(Operator Instructions)
I would now like to pass the call to Larry McGrath, Chief Strategy Officer. Larry, please proceed.
Good morning and welcome to the CVS Health third-quarter 2025 earnings call and webcast. I'm Larry McGrath, Chief Strategy Officer. I'm joined this morning by David Joyner, President and Chief Executive Officer, and Brian Newman, Chief Financial Officer.
Following our prepared remarks, we'll host a question-and-answer session that will include additional members of the leadership team. Our press release and slide presentation have been posted to our website, along with our Form 10-Q filed this morning with the SEC. Today's call is also being broadcast on our website, where it'll be archived for one year.
During this call, we'll make certain forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
